A Phase I study of olaparib and irinotecan in patients with colorectal cancer: Canadian Cancer Trials Group IND 187.
about
Phosphorylated fraction of H2AX as a measurement for DNA damage in cancer cells and potential applications of a novel assayEfficiency of olaparib in colorectal cancer patients with an alteration of the homologous repair protein.Pilot trial of CRLX101 in patients with advanced, chemotherapy-refractory gastroesophageal cancer.The development of PARP as a successful target for cancer therapy.
P2860
A Phase I study of olaparib and irinotecan in patients with colorectal cancer: Canadian Cancer Trials Group IND 187.
description
2016 nî lūn-bûn
@nan
2016 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
A Phase I study of olaparib an ...... n Cancer Trials Group IND 187.
@ast
A Phase I study of olaparib an ...... n Cancer Trials Group IND 187.
@en
type
label
A Phase I study of olaparib an ...... n Cancer Trials Group IND 187.
@ast
A Phase I study of olaparib an ...... n Cancer Trials Group IND 187.
@en
prefLabel
A Phase I study of olaparib an ...... n Cancer Trials Group IND 187.
@ast
A Phase I study of olaparib an ...... n Cancer Trials Group IND 187.
@en
P2093
P2860
P1476
A Phase I study of olaparib an ...... n Cancer Trials Group IND 187.
@en
P2093
Deborah Keller
Derek J Jonker
Eric X Chen
Julie Wells
Karyn McKeever
Lesley Seymour
Lillian L Siu
Linda Hagerman
P2860
P2888
P304
P356
10.1007/S10637-016-0351-X
P577
2016-04-13T00:00:00Z
P6179
1031521811